Charles Schwab Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$698K Buy
8,176
+953
+13% +$86.3K 0.04% 117
2026
Q2
$662K Buy
7,223
+5
+0.1% +$437 0.04% 118
2026
Q1
$615K Buy
7,218
+63
+0.9% +$5.62K 0.04% 103
2025
Q4
$565K Sell
7,155
-46
-0.6% -$3.61K 0.04% 109
2025
Q3
$576K Hold
7,201
– – 0.04% 112
2025
Q2
$655K Hold
7,201
– – 0.05% 105
2025
Q1
$675K Buy
7,201
+1,600
+29% +$143K 0.06% 101
2024
Q4
$509K Hold
5,601
– – 0.04% 109
2024
Q3
$581K Sell
5,601
-18
-0.3% -$1.84K 0.05% 106
2024
Q2
$545K Buy
5,619
+119
+2% +$11K 0.05% 107
2024
Q1
$495K Hold
5,500
– – 0.05% 112
2023
Q4
$438K Hold
5,500
– – 0.04% 122
2023
Q3
$391K Buy
+5,500
New +$411K 0.04% 128

Other funds holding CL

Charles Schwab Trust's CL Position: Q3 2026 in Review

Charles Schwab Trust increased its Colgate-Palmolive (CL) stake by 13% in Q3 2026, buying an estimated $86.3K and bringing the position to 8,176 shares worth $698K. The position accounts for 0.04% of the portfolio, ranked #117.

Charles Schwab Trust first reported a position in CL in Q3 2023 and has held it in 13 quarters since. 1,143 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Charles Schwab Trust held 8,176 shares of Colgate-Palmolive worth $698K as of Q3 2026.
  • Charles Schwab Trust bought 953 Colgate-Palmolive shares in Q3 2026, an estimated $86.3K.
  • Colgate-Palmolive made up 0.04% of Charles Schwab Trust's portfolio in Q3 2026, its #117 holding.
  • Charles Schwab Trust first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 13 quarters since.
  • 1,143 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Charles Schwab Trust's 13F filing for Q3 2026, filed 15 Oct 2026.